There was a support and a mild capitulation upward on the 21st of Sept. before the SEC investigation became public knowledge. The FDA flag and SEC flag both cause heavy sell offs of this equity. You can determine this by charting the news events with stock price. Regardless of Reuters and Mill-brooks' analysis which places a 'buy' rating on this company, institutional and retail investors are on the sideline while robo and model trades aggregate queues from news. At this juncture, QCOR is in a news driven momentum. The SEC investigation will determine anti-competitive strategies were not used and the support level endorse a higher value which will include automated trades.